Fungal infections occur
due to unhygienic, damp, and unclean environment. They are caused by
microscopic organisms that can invade the epithelial tissue. Most dermal
infections are the tinea group of infections and are commonly observed in
people. They affect nails, hair, scalp, and the skin in various areas of the
body. Systemic fungal infections are caused by the ingestion or inhalation of
spores and cause fungal pneumonia and opportunistic fungus causes diseases such
as candidaisis, meningitis, mucormycosis and some others. There is a very broad
base of fungal diseases in humans and infections are a common occurrence.
Although most infections are non-lethal, they are very uncomfortable to live
with and also create stigma or uneasiness for the patients and the people
around them.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/antifungal-drugs.html
Antifungal drugs act in
various mechanisms such as in inhibition of cell wall formation, cell membrane
disruption, and in inhibition of cell division. The market for antifungal
therapies includes different applications such as drugs, powders, ointments,
and pastes. Major market drivers include increasing unhygienic conditions in
developed cities and countries around the world, increasing population coming
in contact with resistant fungal strains and infections. The market is highly
competitive at both global and local levels. The restraints for the market are
the increasing resistance of fungi, use of traditional medicines to control
fungus, and allergic reaction to some types of anti-fungal drugs such as azoles
which cause anaphylaxis.
The antifungal drugs
market is considered to be a very popular over-the-counter drug segment
particularly for dermal infections. Recent advances in technology and drug
delivery has presented targeted therapy to be a vital part of antifungal drugs.
Large numbers of physicians are gaining advantages from other technological
advancements such as diagnostic tests and devices to extract and treat the
correct strain of infection.
Conventional broad
spectrum anti-biotics are not the choice of use now and it is predicted that
the market will continue moving in the current focused trend in the coming
years. Invasive aspergillosis is the new attention of most pharmaceutical
companies and the leading cause of death in transplant operations in people.
Generic competition of the drugs is very strong in the antifungal segment and
is predicted to earn around 65% - 70% of total market revenues.
This research report
analyzes this market depending on its market segments, major geographies, and
current market trends.
Geographies analyzed
under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides
comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming
years
This report is a
complete study of current trends in the market, industry growth drivers, and
restraints. It provides market projections for the coming years. It includes
analysis of recent developments in technology, Porter’s five force model
analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
More Reports on Pharmaceutical Market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About Us:-
Transparency Market Research (TMR) is a
market intelligence company providing global business research reports and
consulting services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insights for thousands of decision-makers.
Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Browse
Market Research Report:-
No comments:
Post a Comment